UA94466C2 - Combination preparations comprising slv308 and a l-dopa - Google Patents
Combination preparations comprising slv308 and a l-dopaInfo
- Publication number
- UA94466C2 UA94466C2 UAA200900253A UAA200900253A UA94466C2 UA 94466 C2 UA94466 C2 UA 94466C2 UA A200900253 A UAA200900253 A UA A200900253A UA A200900253 A UAA200900253 A UA A200900253A UA 94466 C2 UA94466 C2 UA 94466C2
- Authority
- UA
- Ukraine
- Prior art keywords
- slv308
- dopa
- combination preparations
- oxide
- simultaneous
- Prior art date
Links
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 title abstract 2
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- YVPUUUDAZYFFQT-UHFFFAOYSA-N 7-(4-methylpiperazin-1-yl)-3h-1,3-benzoxazol-2-one Chemical compound C1CN(C)CCN1C1=CC=CC2=C1OC(=O)N2 YVPUUUDAZYFFQT-UHFFFAOYSA-N 0.000 abstract 2
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 208000005793 Restless legs syndrome Diseases 0.000 abstract 1
- -1 SLV308 N-oxide Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000010249 dopaminergic function Effects 0.000 abstract 1
- 238000011084 recovery Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention concerns the use of a combination preparation of SLV308 or its N-oxide, or pharmacologically acceptable salts of those compounds (I), (II) and L-DOPA, for simultaneous, separate or sequential use in the treatment of disorders requiring recovery of dopaminergic function, in particular Parkinson's disease and restless leg syndrome., (I)SLV308, (II)SLV308 N-oxide
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06115583 | 2006-06-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA94466C2 true UA94466C2 (en) | 2011-05-10 |
Family
ID=37513845
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200900253A UA94466C2 (en) | 2006-06-16 | 2007-06-15 | Combination preparations comprising slv308 and a l-dopa |
Country Status (7)
| Country | Link |
|---|---|
| CN (1) | CN101516371A (en) |
| AR (1) | AR061355A1 (en) |
| BR (1) | BRPI0713695A2 (en) |
| MX (1) | MX2008016225A (en) |
| SA (1) | SA07280317B1 (en) |
| TW (1) | TW200813038A (en) |
| UA (1) | UA94466C2 (en) |
-
2007
- 2007-06-13 AR ARP070102580A patent/AR061355A1/en not_active Application Discontinuation
- 2007-06-13 SA SA7280317A patent/SA07280317B1/en unknown
- 2007-06-13 TW TW096121305A patent/TW200813038A/en unknown
- 2007-06-15 BR BRPI0713695-1A patent/BRPI0713695A2/en not_active IP Right Cessation
- 2007-06-15 UA UAA200900253A patent/UA94466C2/en unknown
- 2007-06-15 MX MX2008016225A patent/MX2008016225A/en not_active Application Discontinuation
- 2007-06-15 CN CNA2007800225200A patent/CN101516371A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| MX2008016225A (en) | 2009-01-19 |
| TW200813038A (en) | 2008-03-16 |
| AR061355A1 (en) | 2008-08-20 |
| BRPI0713695A2 (en) | 2012-10-30 |
| SA07280317B1 (en) | 2010-09-29 |
| CN101516371A (en) | 2009-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LU93321I2 (en) | IBRUTINIB, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | |
| TW200635582A (en) | Medicaments for the treatment or prevention of fibrotic diseases | |
| WO2006095029A3 (en) | Di-polymer protein conjugates and processes for their preparation | |
| UA92584C2 (en) | Use of meloxicam for the treatment of respiratory diseases in pigs | |
| GEP20125701B (en) | Application of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethyl]-4-fluoro-benzonitrile | |
| MX2009002196A (en) | Buprenophine-wafer for drug substitution therapy. | |
| HK1100765A1 (en) | Use of rotigotine for treating and preventing parkinson's plus syndrome | |
| TW200637522A (en) | Skin treatment articles and methods | |
| UA102517C2 (en) | Substituted morpholine and thiomorpholine derivatives, pharmaceutical composition based thereon and use thereof for the preparation of medicament for the treatment of a disorder or disease of the central nervous system | |
| MX2020008616A (en) | Sublingual fentanyl spray. | |
| MX2010006204A (en) | 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressine-dependent diseases. | |
| TW200637544A (en) | Medicaments for the treatment or prevention of fibrotic diseases | |
| TW200635595A (en) | Medicaments for the treatment of prevention of fibrotic diseases | |
| WO2007144422A3 (en) | Combination preparations comprising bifeprunox and l-dopa | |
| WO2009068708A3 (en) | Pharmaceutical composition with prolonged release of somatostatin or an analogue thereof | |
| MX2008014247A (en) | Aqueous tobacco leaf extract, uses thereof in the treatment of dependence. | |
| ES2325291A1 (en) | Use of a silybum marianum extract | |
| MY148457A (en) | Combination preparations comprising slv308 and a dopamine agonist | |
| UA94466C2 (en) | Combination preparations comprising slv308 and a l-dopa | |
| MY146657A (en) | Use of 4-cyclopropylmethoxy-n- (3,5-dichloro-1-oxido-pyridin-4-yl)-5-(methoxy) pyridine-2-carboxamide for the treatment of spinal cord traumas | |
| BR0313665A (en) | Bupropion for the treatment of restless leg syndrome | |
| UA94465C2 (en) | Combination preparations comprising bifeprunox and l-dopa | |
| WO2007116297A3 (en) | Use of aminapthone for the preparation of a medicament for treating arteriophaties | |
| MY148092A (en) | Use of 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of motor disorders related to parkinson's disease | |
| TW200740825A (en) | Cripowellins and synthetic derivatives thereof as medicaments |